Obstructive Sleep Apnea of Adult Clinical Trial
Official title:
SleepWell24: An Innovative Smartphone Application to Improve PAP Adherence
Verified date | August 2019 |
Source | Arizona State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Obstructive sleep apnea (OSA) is a major public health concern n the United States. Positive airway pressure (PAP) therapy is the treatment-of-choice and "gold standard" for individuals with moderate-to-severe OSA. Regular and sustained PAP use can reduce risk for subsequent disease and improve quality of life. Nevertheless, PAP adherence rates are low. Most PAP adherence programs do not address the self-management skills and strategies that promote adherence and are often too costly and complex to integrate into overburdened clinical environments. Furthermore, they do not leverage opportunities to change lifestyle behaviors that occur across the 24h spectrum (i.e., sleep hygiene, sedentary behavior, physical activity), which have promise to improve OSA symptoms and PAP adherence. The investigators have previously developed and successfully tested BeWell24, a multicomponent smartphone "app" that uses evidence-based behavior change strategies to improve sleep, sedentary, and physical activity behaviors. The investigators will enhance this app to create SleepWell24. Enhancements will include: (1) specific behavior change strategies from the evidence-based Sleep Apnea Self-Management Program to promote PAP adherence; (2) an interface for exchange of patient data to facilitate patient-provider communication on treatment progress; and (3) real-time feedback via wireless integration with a consumer-based PAP machine and wearable sensor. All aspects of this work will be embedded within the Mayo Clinic Arizona Center for Sleep Medicine. The investigators will test the effects of SleepWell24 in newly prescribed PAP users and gather data on the feasibility and acceptability of using SleepWell24 compared to a usual care control group. The investigators will conduct a pilot randomized controlled trial with participants randomly assigned to (1) SleepWell24; or (2) usual care for 60 days post-PAP prescription. The investigators will track recruitment/retention rates, app usage statistics, and measures of treatment satisfaction. The investigators will objectively measure PAP adherence to test whether the SleepWell24 group will have more hours/night of PAP usage compared to the usual care group. In an exploratory fashion, the investigators will also examine the effect of SleepWell24 on selected treatment outcomes (weight, daytime sleepiness, cognitive impairment, and health-related quality of life) and evaluate social cognitive and lifestyle behavior mediators of SleepWell24 on PAP adherence.
Status | Completed |
Enrollment | 119 |
Est. completion date | August 1, 2019 |
Est. primary completion date | July 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Mild to severe obstructive sleep apnea diagnosed through clinical diagnostic testing and laboratory or home-based sleep study - current use of appropriate Apple (iOS7 or higher) or Android (2.3 or higher) smartphone device - Be able to read, write, and understand English - Prescribed positive airway pressure therapy for obstructive sleep apnea Exclusion Criteria: - Do not agree to be randomized - Currently participating in other lifestyle change programs - Personal, health, cognitive, or psychological conditions that prevent full participation - Pregnant, lactating, or trying to become pregnant - Prescribed high-dose benzodiazepines - Daily opioid medication use at night - Unwilling to discontinue use of any current wearable sensor for the duration of the trial - Unwilling to consent for out-of-pocket costs - Previous treatment/referral for claustrophobia - Previous Positive airway pressure therapy use - Planning to travel for more than seven consecutive nights during the trial - Currently engaging in shiftwork |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic | Scottsdale | Arizona |
Lead Sponsor | Collaborator |
---|---|
Arizona State University | Mayo Clinic, National Institute of Nursing Research (NINR) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment and Retention | numbers recruited and retained over the course of the trial | Duration of the trial (~60 days) | |
Primary | SleepWell24 application usage | objective metrics of smartphone application usage by intervention group | Duration of the trial (~60 days) | |
Primary | Treatment acceptability/satisfaction | Intervention acceptability questionnaire for both groups | Baseline vs. Day 60 of trial | |
Primary | Positive airway pressure therapy use | How many hours per night therapy was used throughout the trial | Duration of the trial (~60 days) | |
Secondary | Body Mass Index | body mass index according to weight and height | Baseline and follow-up visit between days 31 and 60 | |
Secondary | Daytime Sleepiness | Epworth Sleepiness Scale | Baseline, Day 30, Day 60 of trial | |
Secondary | Cognitive functioning | Neurocognitive battery | Baseline and follow-up visit between days 31 and 60 | |
Secondary | Global Quality of Life due to physical and mental health via the Patient Reported Outcomes Measurement Information System Global Health Scale | The investigators will measure quality of life in general as informed by current physical and mental health using the quality of life in general as informed by current physical and mental health using the Patient Reported Outcomes Measurement Information System Global Health Scale. This Scale measures an individual's physical, mental, and social health, in general. This measure produces 2 scores: Physical Health and Mental Health. Summed raw scores are converted to T-score values with a mean of 50 and a standard deviation of 10. A higher T score indicates better Global Physical or Mental Health depending on the subscale used. | Baseline, Day 30, Day 60 of trial | |
Secondary | Sleep Apnea-Specific Quality of Life | The investigators will measure functional outcomes of sleep apnea with the Functional Outcomes of Sleep Questionnaire, which measures how difficult it is to carry out certain activities because of daytime sleepiness due to sleep apnea. It is a 10-item questionnaire representing 5 subscales. To obtain the total score, a mean-weighted item score is first computed for subscales with more than one item. Then the total score is derived by calculating the mean of the subscale scores and multiplying that mean by 5. Higher total scores indicate less difficulty with sleepiness due to sleep apnea affecting daytime activities. Scale ranges from 0 to 40. | Baseline, Day 30, Day 60 of trial |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05489562 -
Use of Intraoral Suction and Its Effects on Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05717959 -
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
|
N/A | |
Recruiting |
NCT06008626 -
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT03940781 -
Effects of Rehabilitation for Patients With Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT03122639 -
Endothelial Function in Obstructive Sleep Apnea
|
Early Phase 1 | |
Recruiting |
NCT05289063 -
Vascular Endothelial Dysfunction in Sleep Apnea
|
Phase 1 | |
Not yet recruiting |
NCT05268471 -
Cost-effectiveness Analysis and Conditional Response to the Effect of Positional Devices in Obstructive Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT04864652 -
Safety and Dosing Study of the CHILLS Cryotherapy for the Treatment of OSA
|
N/A | |
Enrolling by invitation |
NCT05433883 -
The Relationship Between Obstructive Sleep Apnea and Alzheimer's Disease: Evidence and Effectiveness
|
N/A | |
Recruiting |
NCT06103630 -
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
|
N/A | |
Recruiting |
NCT06283095 -
Management of Obstructive Sleep Apnea Syndrome by Expansion Palatoplasty
|
N/A | |
Completed |
NCT03362385 -
OSA-ACS Project: Association of OSA and CPAP Therapy With Outcomes in ACS Patients
|
||
Recruiting |
NCT06447818 -
Changes in Difficult Airway Markers After Surgery for Obstructive Sleep Apnoea Syndrome
|
||
Completed |
NCT04643782 -
Comparative Study of the ANNEā¢ One System to Diagnose Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT03463785 -
Does Race Make a Difference in Obstructive Sleep Apnea?
|
||
Recruiting |
NCT03618719 -
Impact of Intermittent Hypoxia on the Function of the Phagocytes
|
||
Completed |
NCT03048604 -
BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)
|
N/A | |
Recruiting |
NCT05290350 -
Long COVID-19 Fatigue and Obstructive Sleep Apnea
|
||
Recruiting |
NCT05739617 -
Comprehensive Respiratory Training Exercise Program in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT03980158 -
Change in Tongue Strength and Fatigue After Upper Airway Stimulation Therapy
|